Skip to main content
. 2014 Nov 19;9:1307–1314. doi: 10.2147/COPD.S71849

Table 1.

Demographic characteristics

GOLD stage Stage I
N=43
Stage II
N=167
Stage III
N=362
Stage IV
N=294
Total
N=866
Sexb male (%) 38 (88.4) 136 (81.4) 328 (90.6) 256 (87.1) 758 (87.5)
Age, years (SD)b 65.9 (10.2) 68.0 (10.9) 70.1 (9.4) 70.9 (9.01) 69.8 (9.7)
BMI, kg/m2 28.0 (4.3) 27.0 (4.2) 28.0 (4.8) 27.0 (4.6) 27.5 (4.6)
Smoking statusb
 Ex-smoker 29 (67.4%) 119 (71.3%) 287 (79.2%) 238 (80.9%) 673 (77.8%)
 Smoker 14 (32.6%) 48 (28.7%) 75 (20.8%) 56 (19.1%) 193 (22.2%)
Pack-years (interquartile range)a,c 30.0 (22.5/45.0) 36.0 (20.0/51.0) 40.5 (28.4/60.0) 48.0 (31.3/67.5) 41.3 (30.0/60.0)
Dyspnea (MRC)c 1.0 (0.7) 1.2 (0.9) 2.3 (0.9) 3.2 (0.9) 2.3 (1.2)
FEV1, % predictedc 85.2 (5.7) 63.7 (8.7) 40.4 (5.9) 25.6 (4.1) 42.1 (17.7)
SaO2, %c 92.6 (4.0) 91.3 (7.3) 89.6 (6.6) 85.9 (8.8) 89.1 (7.8)
No of days in hospital for any cause during previous 12 months (interquartile range)a,b 8.0 (7.0/16.0) 12.0 (8.0/24.0) 12.5 (8.0/26.0) 20.0 (10.0/37.0) 15.0 (8.0/29.0)

Notes: Quantitative data presented as mean (SD) unless otherwise stated.

a

Median (interquartile range)

b

Significant group differences (P<0.05)

c

Significant group differences (P<0.001).

Abbreviations: BMI, body mass index; FEV1, forced vital capacity in 1 second; GOlD, Global Initiative for Chronic Obstructive Lung Disease; MRC, Medical Research Council; SD, standard deviation.